The current study aimed to explore the lived experience of patients with hepatitis C virus infection. Semi-structured interviews were conducted with seven male participants living with hepatitis C virus and were analysed using interpretative phenomenological analysis. Two master themes were identified: (1) diagnosis and the search for meaning and (2) impact of stigma on disclosure. Participants reported fears of contaminating others, feelings of stigma and concerns of disclosing the condition to others. Response to diagnosis, stigma and disclosure among the participants appeared to be interrelated and directly related to locus of blame for virus contraction. More specifically, hepatitis C virus transmission via medical routes led to an externalisation of culpability and an openness to disclosure. Transmission of hepatitis C virus as a direct result of intravenous drug use led to internalised blame and a fear of disclosure. The inter- and intra-personal consequences of hepatitis C virus explored in the current study have potential implications for tailoring future psychological therapy and psychoeducation to the specific needs of the hepatitis C virus population.
AudetCMMcGowanCCWallstonKA, et al. (2013) Relationship between HIV stigma and self-isolation among people living with HIV in Tennessee. PLoS ONE8(8): e69564.
2.
BerenguerMPrietoMRayónJM, et al. (2000) Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology32: 852–858.
3.
BlachSZeuzemSMannsM, et al. (2017) Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study. The Lancet Gastroenterology & Hepatology2(3): 161–176.
4.
BrenerLHorwitzRvon HippelC, et al. (2015) Discrimination by health care workers versus discrimination by others: Countervailing forces on HCV treatment intentions. Psychology, Health & Medicine20(2): 148–153.
5.
BrockiJMWeardenAJ (2006) A critical evaluation of the use of interpretative phenomenological analysis (IPA) in health psychology. Psychology & Health21: 87–108.
6.
BuryM (1982) Chronic illness as biographical disruption. Sociology of Health and Illness4(2): 167–182.
7.
ButtGPatersonBMcGuinnessLK (2008) Living with the stigma of hepatitis C. Western Journal of Nursing Research30(2): 204–221.
8.
CamaEBrenerLWilsonH, et al. (2016) Internalized stigma among people who inject drugs. Substance Use & Misuse51(12): 1664–1668.
9.
Centers for Disease Control and Prevention (2017) Viral hepatitis. Available at: www.cdc.gov/hepatitis/hcv/hcvfaq.htm (accessed 4 February 2018).
10.
ConradSGarrettLFCooksleyWGE, et al. (2006) Living with chronic hepatitis C means ‘you just haven’t got a normal life any more’. Chronic Illness2(2): 121–131.
11.
CrockettBGiffordSM (2004) ‘Eyes wide shut’: Narratives of women living with hepatitis C in Australia. Women & Health39(4): 117–137.
12.
CroftsNLouieRLoffB (1997) Stigmatization and discrimination related to hepatitis C virus infection in Australia. Health and Human Rights2(2): 86–97.
13.
DuffinJ (2005) Lovers and Livers: Disease Concepts in History. Toronto, ON: University of Toronto Press Incorporated.
14.
DunneEAQuayleE (2001) The impact of latrogenically acquired hepatitis C infection on the well-being and relationships of a group of Irish women. Journal of Health Psychology6(6): 679–692.
15.
FraserS (2004) ‘It’s your life!’: Injecting drug users, individual responsibility and hepatitis C prevention. Health8(2): 199–221.
16.
FraserSTreloarC (2006) ‘Spoiled identity’ in hepatitis C infection: The binary logic of despair. Critical Public Health16: 99–110.
17.
HarrisM (2009) Injecting, infection, illness: Abjection and hepatitis C stigma. Body & Society15: 33–52.
18.
Hepatitis C, Virus Projections Working Group (2006) Estimates and projections of the hepatitis C virus epidemic in Australia 2006, Canberra Hepatitis C Sub-Committee, Ministerial Advisory Committee on AIDS Sexual Health and Hepatitis. Available at: http://www.nchecr.unsw.edu.au/NCHECRweb.nsf/resources/HCVPWG2006/$file/HCVPWGRepAug06.pdf (accessed 22 June 2013).
19.
HepworthJKrugGJ (1999) Hepatitis C: A socio-cultural perspective on the effects of a new virus on a community’s health. Journal of Health Psychology4: 237–246.
20.
HillRPfeilMMooreJ, et al. (2015) Living with hepatitis C: A phenomenological study. Journal of Clinical Nursing24(3–4): 428–438.
21.
HopwoodMTreloarC (2003) The 3D Project: Diagnosis, Disclosure, Discrimination and Living with Hepatitis C. Sydney, NSW, Australia: National Centre in HIV Social Research.
22.
LekasHSiegelKLeiderJ (2011) Felt and enacted stigma among HIV/HCV-coinfected adults: The impact of stigma layering. Qualitative Health Research21: 1205–1219.
23.
LoweDCottonR (1999) Hepatitis C: A Review of Australia’s Response. Canberra, ACT, Australia: Department of Health and Aged Care.
24.
MaynardR (2006) Controlling death–Compromising life: Chronic disease, prognostication, and the new biotechnologies. Medical Anthropology Quarterly20(2): 212–234.
25.
OlsenABanwellCDanceP (2013) Reinforced biographies among women living with hepatitis C. Qualitative Health Research23(4): 531–540.
26.
PatersonBLButtGMcGuinnessL, et al. (2006) The construction of hepatitis C as a chronic illness. Clinical Nursing Research15(3): 209–224.
27.
PoynardT (2005) Hepatitis C and B: Management and Treatment. 2nd ed.London and New York: Taylor and Francis.
PungpapongSAqelBLeiseM, et al. (2015) Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant. Hepatology61(6): 1880–1886.
31.
ScamblerG (2004) Re-framing stigma: Felt and enacted stigma and challenges to the sociology of chronic and disabling conditions. Social Theory & Health2: 29–46.
32.
SchaferAScheurlenMFeltenM, et al. (2005) Physician–patient relationship and disclosure behaviour in chronic hepatitis C in a group of German outpatients. European Journal of Gastroenterology & Hepatology17: 1387–1394.
StuenkelDWongV (2009) Stigma. In: LarsenPLubkinI (eds) Chronic Illness: Impact and Intervention. Burlington, MA: Jones & Bartlett Publishers.
35.
SuarezAE (2010) Racial disparities in knowledge of hepatitis C virus (HCV). In: KronenfeldJJ (ed.) The Impact of Demographics on Health and Health Care: Race, Ethnicity and Social Factors. Bingley: Emerald Group Publishing, pp. 21–46.
36.
SyTMazen JamalM (2006) Epidemiology of hepatitis C virus (HCV) infection. International Journal of Medical Sciences3(2): 41–46.
37.
TompkinsCNEWrightNMJJonesL (2005) Impact of a positive hepatitis C diagnosis on homeless injecting drug users: A qualitative study. British Journal of General Practice55(513): 263–268.
38.
TreloarCHopwoodM (2004) Infection control in the context of hepatitis C disclosure: Implications for education of healthcare professionals. Education for Health17: 183–191.
39.
TreloarCRhodesT (2009) The lived experience of hepatitis C and its treatment among injecting drug users: Qualitative synthesis. Qualitative Health Research19(9): 1321–1334.
YardleyL (2000) Dilemmas in qualitative health research. Psychology & Health15: 215–228.
42.
ZickmundSHoEYMasudaM, et al. (2003) ‘They treated me like a leper’. Stigmatization and the quality of life of patients with hepatitis C. Journal of General Internal Medicine18(10): 835–844.
